4
Changes in Ownership
Teladoc Health, Inc. Filed Acc 0001415889-23-004415
CHIEF EXECUTIVE OFFICER sold 22,040 shares at $25.91 ($571,078)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GOREVIC JASON N CHIEF EXECUTIVE OFFICER | 2023-03-03 | Sale | −22,040 | $25.91 | $571,078 | 603,434 | D: show line 1 in the form |
| Open-market sales · 22,040 sh · avg $25.91 · $571,078 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| GOREVIC JASON N CHIEF EXECUTIVE OFFICER | 2023-03-03 | Grant or award · Restricted Stock Units | +186,012 | 186,012 | D: show line 2 in the form |
Loading xslF345X03/form4-03072023_090335.xml…